Celestica HPS Sales Soar 72% to $1.4B While Q4 CCS Revenue Jumps 64%
Celestica’s stock has risen 49.6% since August 2025, driven by high-performance solutions now representing 38% of revenue with 72% year-over-year segment sales growth to $1.4 billion. In Q4, CCS revenues jumped 64% and cash flow surged, but valuation risks remain because of customer concentration and automated test systems weakness.
1. Stock Performance and Valuation
Since August 2025, Celestica has delivered a remarkable 49.62% total return, significantly outpacing the S&P 500’s 8.40% gain over the same period. This stronger-than-market performance has been driven in part by renewed investor interest in capital‐intensive technology manufacturers. Celestica’s forward price/earnings‐to‐growth (PEG) ratio for fiscal year 2027 stands at just 0.50, suggesting that consensus estimates for mid‐teens percentage revenue growth are not fully reflected in the current valuation. With earnings estimates rising 18% over the next 12 months and a price/earnings multiple below peers in the electronics manufacturing services industry, Celestica appears positioned for continued upside.
2. High Performance Solutions Segment Drives Growth
Celestica’s High Performance Solutions (HPS) segment now accounts for 38% of consolidated revenue, reflecting customers’ increasing demand for advanced thermal management, precision metal fabrication and ruggedized electronics. In the latest fiscal year, HPS sales jumped 72% year‐over‐year to $1.4 billion, outpacing the company’s overall revenue growth of 28%. Management has highlighted a robust $4.8 billion backlog in aerospace and defense programs, as well as multi‐year contracts in high‐performance computing, which provide clear visibility into above‐average margins of 9.5% compared with the corporate average of 6.8%.
3. Q4 Earnings Highlights and Investor Considerations
In the fourth quarter, Celestica reported a 64% increase in Customer & Cloud Solutions (CCS) revenues, driven by hyperscale data center demand and expanded service offerings in Asia Pacific. Operating cash flow surged to $185 million, up 43% year‐over‐year, bolstered by disciplined working capital management. Despite these strengths, investors should weigh potential headwinds: the top five customers continue to represent over 55% of revenue, exposing Celestica to concentration risk; expectations for its Automated Test Solutions (ATS) business have softened due to delays in customer certification cycles; and the company’s trailing valuation remains at a slight premium to peers based on EV/EBITDA multiples. Analysts maintain a consensus buy rating but note that short‐term share price volatility could arise if end‐market spending slows.